Get started
Author

G. Caleb Alexander

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016
2018 · Thomas J. Moore, Hanzhe Zhang, et al. · JAMA Internal Medicine · 368
PDF
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study
2020 · Thomas J Moore, James Heyward, et al. · BMJ Open · 117
PDF
Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease
2024 · Hai V. Nguyen, Shweta Mital, et al. · Neurology · 87
Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic Products
2020 · Thomas J. Moore, Morgane C. Mouslim, et al. · JAMA Internal Medicine · 51
PDF
Estimated costs of pivotal trials for U.S. Food and Drug Administration–approved cancer drugs, 2015–2017
2020 · Emily Han-Chung Hsiue, Thomas J Moore, et al. · Clinical Trials · 21
Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015–2016
2019 · Yao Qiao, G Caleb Alexander, et al. · Clinical Trials · 20
Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development
2023 · Morgan A. Butrovich, Allison C. Reaves, et al. · Clinical Journal of the American Society of Nephrology · 19
PDF
Characteristics of Copayment Offsets for Prescription Drugs in the United States
2021 · Aditi P. Sen, So-Yeon Kang, et al. · JAMA Internal Medicine · 19
PDF
Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US
2025 · Minji Kim, Michael A. Schweitzer, et al. · JAMA Surgery · 18
PDF
Exposure– and Dose–response Analyses in Dose Selection and Labeling of FDA-approved Biologics
2017 · Ken Ogasawara, Christopher D. Breder, et al. · Clinical Therapeutics · 18
Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs
2019 · Irene B. Murimi-Worstell, Jeromie M. Ballreich, et al. · PLoS ONE · 10
PDF
Is artificial intelligence a friend or foe to epidemiology?
2026 · Emaan Rashidi, Madeline Brooks, et al. · Annals of Epidemiology · 4
Cash and Commercial Negotiated Prices of Physician-Administered Drugs in US Hospitals
2026 · Angela Liu, Yang Wang, et al. · The American Journal of Managed Care · 1
Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors
2025 · Xinyi Sun, James Heyward, et al. · Journal of Immunotherapy · 1
Screening, brief intervention, and referral to treatment training for Nigerian primary care physicians: A pilot evaluation of knowledge, attitudes, self-efficacy, and barriers to implementation
2025 · Honest Anaba, Johannes Thrul, et al. · PLOS Global Public Health
PDF
Underrepresentation of black individuals in pivotal trials for novel anticancer drugs: Potential consequence of using estimated creatinine clearance to assess kidney function?
2024 · Morgan A. Butrovich, Allison C. Reaves, et al. · Contemporary Clinical Trials
Works count: 16
Citation count: 754
H-index: 10
I10-index: 11
Year
Topic
Type